Yu Mi
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 17
- Nanoparticle-Based Drug Delivery 16
-
- RNA Interference and Gene Delivery 6
- Advanced biosensing and bioanalysis techniques 4
- Co-authors
- Si‐Shen Feng (10 shared papers)Jing Zhao (6 shared papers)Andrew Z. Wang (14 shared papers)Yutao Liu (3 shared papers)Benjamin G. Vincent (4 shared papers)C. Tilden Hagan (4 shared papers)Kyle C. Roche (5 shared papers)Feifei Yang (6 shared papers)
- Journals
- Biomaterials (6 papers)Advanced Science (3 papers)Pharmacological Research (2 papers)Advanced Materials (2 papers)Cancer Research (2 papers)
- Partner nations
- United StatesChinaSingapore
In The Last Decade
Yu Mi
31 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 97
- Biomaterials 798
- Pharmaceutical Science 107
- Biomedical Engineering 730
- Immunology 242
- Oncology 289
Countries citing papers authored by Yu Mi
This map shows the geographic impact of Yu Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Mi more than expected).
Fields of papers citing papers by Yu Mi
This network shows the impact of papers produced by Yu Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Mi. The network helps show where Yu Mi may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Mi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 235 | |
| 2 | 2018 | 177 | |
| 3 | 2019 | 146 | |
| 4 | 2013 | 136 | |
| 5 | 2016 | 121 | |
| 6 | 2012 | 106 | |
| 7 | 2013 | 81 | |
| 8 | 2012 | 75 | |
| 9 | 2018 | 73 | |
| 10 | 2021 | 57 | |
| 11 | 2016 | 52 | |
| 12 | 2011 | 52 | |
| 13 | 2016 | 42 | |
| 14 | 2011 | 33 | |
| 15 | 2011 | 25 | |
| 16 | 2016 | 24 | |
| 17 | 2019 | 23 | |
| 18 | 2020 | 22 | |
| 19 | 2020 | 19 | |
| 20 | 2011 | 14 |
About Yu Mi
Yu Mi is a scholar working on Biomaterials, Molecular Biology, Biomedical Engineering, Oncology and Immunology, having authored 31 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (16 papers), Nanoplatforms for cancer theranostics (9 papers), RNA Interference and Gene Delivery (6 papers), Immunotherapy and Immune Responses (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Dendrimers and Hyperbranched Polymers (3 papers) and Intestinal and Peritoneal Adhesions (2 papers). The work is most often cited by research in Biomaterials (798 citations), Pharmaceutical Science (107 citations), Biomedical Engineering (730 citations), Immunology (242 citations) and Oncology (289 citations). Yu Mi has collaborated with scholars based in United States, China and Singapore. Frequent co-authors include Si‐Shen Feng, Jing Zhao, Andrew Z. Wang, Yutao Liu, Benjamin G. Vincent, C. Tilden Hagan, Kyle C. Roche, Feifei Yang, Yanfei Qi and Jing Zhao. Their work appears in journals such as Biomaterials, Advanced Science, Pharmacological Research, Advanced Materials and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.